As assisted-suicide laws expand worldwide to include individuals diagnosed with mental disorders, the Citizens Commission on ...
Delivered full-year revenue of $981.3 million, well above upper end of guidance and the highest reported revenue in the Company's 30-year historyFull-year revenue growth of 4.5%, currency neutral grow ...
Rafael Holdings, Inc. (NYSE: RFL) today reported its financial results for the second quarter fiscal year 2026 ended January 31, 2026. "We remain pleased ...
As much as I may hate to admit it, I am now considered to be in the middle-age demographic. I have lived through being a teenager and having a teenager ...
Enhertu (trastuzumab deruxtecan), a HER2-directed antibody drug conjugate (ADC), is approved in the US and several other countries for HER2-positive advanced gastric cancer. Enhertu is jointly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results